Brixmor (NYSE: BRX) is a real estate investment trust (REIT) that owns and operates a high-quality, national portfolio of open-air shopping centers. Its 363 retail centers comprise approximately 64 million square feet of prime retail space in established trade areas. The Company strives to own and operate shopping centers that reflect Brixmor's vision "to be the center of the communities we serve" and are home to a diverse mix of thriving national, regional and local retailers. Brixmor is a proud real estate partner to over 5,000 retailers including The TJX Companies, The Kroger Co., Publix Super Markets and Ross Stores.

Brixmor Property Group Inc.

There’s a lot to be optimistic about in the Real Estate sector as 3 analysts just weighed in on American Tower (AMT – Research Report), Brixmor Pro...

Analysts Offer Insights on Real Estate Companies: American Tower (AMT), Brixmor Property (BRX) and Invitation Homes (INVH)

Forte Biosciences Inc. ( ($FBRX) ) has released its Q3 earnings. Here is a breakdown of the information Forte Biosciences Inc. presented to its inv...

Forte Biosciences Reports Increased R&D Costs Amid Clinical Progress

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on RenovoRx (RNXT – Research Report) and Forte Bioscien...

Analysts Offer Insights on Healthcare Companies: RenovoRx (RNXT) and Forte Biosciences (FBRX)

An announcement from LB Pharmaceuticals, Inc. ( ($LBRX) ) is now available. On November 12, 2025, LB Pharmaceuticals announced the appointment of K...

LB Pharmaceuticals Appoints New Chief Commercial Officer

Belararox Ltd. ( ($AU:BRX) ) has shared an announcement. Belararox Limited announced that all resolutions were passed at its 2025 Annual General Me...

Belararox Limited Successfully Passes All Resolutions at 2025 AGM

LB Pharmaceuticals, Inc. ( ($LBRX) ) has released its Q3 earnings. Here is a breakdown of the information LB Pharmaceuticals, Inc. presented to its...

LB Pharmaceuticals Reports Strong Q3 and Strategic Progress

Belararox Ltd. ( ($AU:BRX) ) has shared an update. Belararox Ltd. announced the cessation of certain securities due to unmet conditions. This inclu...

Belararox Ltd. Announces Cessation of Securities

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Zimmer Biomet Holdings (ZBH – Research Report), Im...

Analysts Offer Insights on Healthcare Companies: Zimmer Biomet Holdings (ZBH), ImmunityBio (IBRX) and Geron (GERN)

Brixmor Property ( ($BRX) ) has issued an update. On October 28, 2025, Brixmor Property Group Inc. announced a new share repurchase program for up ...

Brixmor Property Launches $400M Share Repurchase Program

Moleculin Biotech ( ($MBRX) ) has shared an announcement. On October 29, 2025, Moleculin Biotech announced the granting of an Australian patent for...

Moleculin Biotech Secures Australian Patent for Annamycin

In a report released today, Steve Sakwa from Evercore ISI maintained a Buy rating on Brixmor Property, with a price target of $32.00. The company’s...

Evercore ISI Sticks to Their Buy Rating for Brixmor Property (BRX)

Forte Biosciences Inc. (($FBRX)) announced an update on their ongoing clinical study. Forte Biosciences Inc. is currently conducting a Phase 2 clin...

Current Quarter	$0.57	Next Quarter	$0.58
Current Year	$2.24	Next Year	$2.35
QoQ Growth	+1.8%	YoY Growth	+4.9%
3Y EPS CAGR	+7.2%	Target Price	$30.63
Consensus	Buy	Upside	+15.3%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	BRX	$26.57	+2.25%	1.00M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	BRX	$26.57	+2.3%	1.00M
3
4
5
6

BRX

BRX

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Brixmor Property Group Inc. Data in Excel

Get Brixmor Property Group Inc. Data in Excel